R.M. Abra
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 15
- Pharmaceutical Science top 5%
-
- RNA Interference and Gene Delivery 8
- Advanced biosensing and bioanalysis techniques 4
- Lipid Membrane Structure and Behavior 3
- Protein Interaction Studies and Fluorescence Analysis 2
-
- Inhalation and Respiratory Drug Delivery 4
-
- Radiopharmaceutical Chemistry and Applications 5
-
- Pharmacological Effects and Assays 2
- Co-authors
- C. Anthony HuntAnthony H. C. HuangJan VaagePeter K. WorkingPeter J. QuinnPaul S. UsterEmilio Barberá‐GuillemKevin J. Harrington
- Journals
- Cancer (3 papers)Journal of Liposome Research (3 papers)British Journal of Cancer (2 papers)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
R.M. Abra
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Biomaterials 498
- Pharmaceutical Science 102
- Oncology 215
- Molecular Biology 509
- Pulmonary and Respiratory Medicine 200
Countries citing papers authored by R.M. Abra
This map shows the geographic impact of R.M. Abra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.M. Abra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.M. Abra more than expected).
Fields of papers citing papers by R.M. Abra
This network shows the impact of papers produced by R.M. Abra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.M. Abra. The network helps show where R.M. Abra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R.M. Abra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 8 | |
| 2 | Folate receptor targeting of pegylated liposomal cisplatin enhances anti-tumor activity in mouse models without increasing toxicity | 2002 | 2 |
| 3 | 2002 | 43 | |
| 4 | 2001 | 67 | |
| 5 | 2000 | 74 | |
| 6 | 2000 | 76 | |
| 7 | 1999 | 40 | |
| 8 | 1994 | 133 | |
| 9 | 1994 | 57 | |
| 10 | 1994 | 16 | |
| 11 | 1993 | 83 | |
| 12 | 1992 | 32 | |
| 13 | 1989 | 41 | |
| 14 | 1987 | 8 | |
| 15 | 1984 | 51 | |
| 16 | 1983 | 5 | |
| 17 | 1981 | 204 | |
| 18 | Liposome disposition in vivo: effects of pre-dosing with lipsomes. | 1980 | 29 |
| 19 | 1980 | 2 | |
| 20 | 1976 | 23 |
About R.M. Abra
R.M. Abra is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging, Occupational Therapy, Radiation and Molecular Biology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), RNA Interference and Gene Delivery (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Inhalation and Respiratory Drug Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Lipid Membrane Structure and Behavior (3 papers), Pharmacological Effects and Assays (2 papers) and Protein Interaction Studies and Fluorescence Analysis (2 papers). The work is most often cited by research in Biomaterials (498 citations), Pharmaceutical Science (102 citations), Oncology (215 citations), Molecular Biology (509 citations) and Pulmonary and Respiratory Medicine (200 citations). R.M. Abra has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include C. Anthony Hunt, Anthony H. C. Huang, Jan Vaage, Peter K. Working, Peter J. Quinn, Paul S. Uster, Emilio Barberá‐Guillem, Kevin J. Harrington, Konstantinos N. Syrigos and Gail Rowlinson‐Busza. Their work appears in journals such as Cancer, Journal of Liposome Research, British Journal of Cancer, International Journal of Pharmaceutics and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.